Stran & Company Reports $33.4 Million In Revenue And $0.6 Million In EBITDA For The Second Quarter Of 2026

Stran & Company Reports $33.4 Million In Revenue And $0.6 Million In EBITDA For The Second Quarter Of 2026. Conference Call to be Held Wednesday, August 12, 2026 at 10:00 a.m. Eastern TimeQUINCY, Mass ...

Mineralys Therapeutics Reports Second Quarter 2026 Financial Results And Provides Corporate Update

Mineralys Therapeutics Reports Second Quarter 2026 Financial Results And Provides Corporate Update. – PDUFA target date of December 22, 2026 for lorundrostat; commercial preparations on-track for ...
Mena FN

INTEGRA REPORTS SECOND QUARTER 2026 RESULTS 30% INCREASE IN QUARTERLY GOLD PRODUCTION, RECORD TOTAL TONNES MINED AND STRENGTHENED FINANCIAL POSITION

VANCOUVER, BC, Aug. 11, 2026 /PRNewswire/ -- Integra Resources Corp. ("Integra" or the "Company") (TSXV: ITR) (NYSE American: ITRG) is pleased to announce financial and operating results for the three ...

New Medstar Health Urgent Care Location To Provide Expanded Services For Gallaudet University Students

New Medstar Health Urgent Care Location To Provide Expanded Services For Gallaudet University Students. WASHINGTON, Aug. 11, 2026 /PRNewswire/ -- D.C. residents now have greater access to urgent care ...

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results. New data presented at Digestive Disease Week (DDW) demonstrating improvement of fibrosis and inflammation following a single tre ...

Apollomics Announces $10 Million Private Placement Transaction

Apollomics Announces $10 Million Private Placement Transaction. FOSTER CITY, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM ) (“Apollomics” or the“Company”), a late-stage clin ...

Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results And Highlights Recent Activity

Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results And Highlights Recent Activity. WILMINGTON, Del., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ...
Mena FN

Pixelworks Reports Second Quarter 2026 Financial Results

Pixelworks Reports Second Quarter 2026 Financial Results. PORTLAND, Ore., Aug. 11, 2026 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW ) (Pixelworks or the Company), a provider of innovative cinematic ...

Taysha Gene Therapies Reports Second Quarter 2026 Financial Results And Provides Corporate Update

Taysha Gene Therapies Reports Second Quarter 2026 Financial Results And Provides Corporate Update. Completed dosing in the REVEAL pivotal (N=17) and ASPIRE (N=4) trials evaluating TSHA-102 for Rett ...

Mobile Infrastructure Reports Second Quarter 2026 Financial Results

Mobile Infrastructure Reports Second Quarter 2026 Financial Results. Same-Location Revenue Growth in the Second Quarter on Continued Utilization Gains Contract Parking Volumes Grew Approximately 12% Y ...

Volitionrx Limited Schedules Second Quarter 2026 Earnings Conference Call And Business Update

Volitionrx Limited Schedules Second Quarter 2026 Earnings Conference Call And Business Update. Conference call to take place on Friday, August 14 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev., Aug. 11 ...

Macrogenics Announces Achievement Of $10 Million Milestone Following Gilead's Exercise Of Option To License Preclinical Bispecific Program

Macrogenics Announces Achievement Of $10 Million Milestone Following Gilead's Exercise Of Option To License Preclinical Bispecific Program. ROCKVILLE, MD, Aug. 11, 2026 (GLOBE NEWSWIRE) -- MacroGenics ...